Sorrento Therapeutics, Inc. (SRNE): Price and Financial Metrics
Sorrento Therapeutics, Inc. (SRNE)
Today's Latest Price: $4.12 USD
0.26 (6.74%)
Updated Jun 5 4:00pm
Add SRNE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SRNE Stock Summary
- With a price/sales ratio of 26.17, Sorrento Therapeutics Inc has a higher such ratio than 94.48% of stocks in our set.
- Revenue growth over the past 12 months for Sorrento Therapeutics Inc comes in at 56.52%, a number that bests 90.86% of the US stocks we're tracking.
- The volatility of Sorrento Therapeutics Inc's share price is greater than that of 88.5% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to SRNE, based on their financial statements, market capitalization, and price volatility, are VERU, IOTS, KPTI, NWBO, and RDUS.
- Visit SRNE's SEC page to see the company's official filings. To visit the company's web site, go to www.sorrentotherapeutics.com.
SRNE Daily Price Range
SRNE 52-Week Price Range
SRNE Stock Price Chart More Charts
SRNE Price/Volume Stats
| Current price | $4.12 | 52-week high | $10.00 |
| Prev. close | $3.86 | 52-week low | $1.39 |
| Day low | $4.00 | Volume | 33,729,243 |
| Day high | $4.56 | Avg. volume | 17,979,195 |
| 50-day MA | $3.22 | Dividend yield | N/A |
| 200-day MA | $2.73 | Market Cap | 863.92M |
Sorrento Therapeutics, Inc. (SRNE) Company Bio
Sorrento Therapeutics is a clinical stage oncology company developing new treatments for cancer and associated pain. The company was founded in 2006 and is based in San Diego, California.
Loading social stream, please wait...